Related content

Translocator Protein (TSPO) in Breast Cancer

By  

Current Molecular Medicine, Vol. 12, Iss. 4, 2012-01 ,pp. : 443-457

Bentham Science Publishers

Access to resources Recommend Favorite

Engineering Tissue Model for Anti-Breast Cancer Pharmacotherapy

By  

Current Tissue Engineering, Vol. 1, Iss. 1, 2012-10 ,pp. : 15-23

Bentham Science Publishers

Access to resources Recommend Favorite

Anthracyclinebased induction chemotherapy followed by concurrent cyclophosphamide, methotrexate and 5fluorouracil and radiation therapy in surgically resected axillary nodepositive breast cancer

By                  

Molecular and Clinical Oncology, Vol. 2, Iss. 3, 2014-01 ,pp. : 473-478

Spandidos Publications

Access to resources Recommend Favorite

Aberrant Expression of CXCR4 Significantly Contributes to Metastasis and Predicts Poor Clinical Outcome in Breast Cancer

By  

Current Molecular Medicine, Vol. 14, Iss. 1, 2014-01 ,pp. : 174-184

Bentham Science Publishers

Access to resources Recommend Favorite

Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcome

By Surowiak Paweł   Materna Verena   Maciejczyk Adam   Pudełko Marek   Markwitz Ewa   Spaczyński Marek   Dietel Manfred   Zabel Maciej   Lage Hermann  

Virchows Archiv, Vol. 450, Iss. 3, 2007-03 ,pp. : 279-285

Springer Publishing Company

Access to resources Recommend Favorite